Cargando…
Routine Inflammatory Markers Are Elevated in Myelodysplastic Syndromes at Presentation
Autores principales: | Oster, Howard S., Sklyar, Ekaterina, Golsdshmidt, Noa, Mittelman, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332346/ https://www.ncbi.nlm.nih.gov/pubmed/37435032 http://dx.doi.org/10.4084/MJHID.2023.044 |
Ejemplares similares
-
Thrombocytopenia in Patients with Myelodysplastic Syndromes: Still an Unsolved Problem
por: Basood, May, et al.
Publicado: (2018) -
Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?
por: Book, Reut, et al.
Publicado: (2023) -
The French-American-British classification of myelodysplastic syndromes
por: Mittelman, Moshe
Publicado: (2023) -
Hyperimmunoglobulin D Syndrome Presenting with Volvulus Due to Abdominal Fibro-Inflammatory Bands
por: Kaan Aslan, Muzaffer, et al.
Publicado: (2023) -
Serum Hypoalbuminemia Is a Long-Term Prognostic Marker in Medical Hospitalized Patients, Irrespective of the Underlying Disease
por: Oster, Howard S., et al.
Publicado: (2022)